New Mexico’s Medical Psilocybin Program begins accepting producer permit applications, marking a critical step towards therapeutic access for qualifying patients.

UK employers must apply existing duty of care and disability laws to medical cannabis patients, ensuring fair assessment and reasonable adjustments in the workplace.

Illinois officials propose a rule change to allow outdoor commercial cannabis cultivation. This could significantly reduce costs and expand canopy for licensed growers in the US state.

Germany's recent health insurance reform has thrown medical cannabis reimbursement into disarray, affecting patients and pharmacies alike. Learn about the shifting rules and the impact on access.

Curaleaf's unsolicited bid for Aurora Cannabis signals a major consolidation in the European medical cannabis market, highlighting strategic shifts and growth in the region.

California's DCC issued a voluntary recall for a cannabis product. Packaging with a figurine violated rules by being attractive to children. Consumers advised to return or dispose.

UNODC report shows global cannabis use up 40% over 10 years, with a complex mix of policy reform and growing illicit market overlap. Understand global cannabis trends.

New York has enacted a new law permitting licensed cannabis sales at farmers markets and community events, aiming to bolster small growers and expand consumer access.

Releaf Clinic scales UK medical cannabis, focusing on unique recruitment, robust patient support, and clinical data. Discover their approach amidst national healthcare reform and impact on patients.